Publication Name	World Journal of Gastroenterology
Manuscript ID	5731
Country	Italy

Received	2013-09-25 08:17
Peer-Review Started	2013-09-25 11:19
First Decision by Editorial Office Director
Return for Revision	2013-10-23 09:38
Revised	2013-10-29 17:09
Publication Fee Transferred
Second Decision by Editor	2013-11-13 11:52
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2013-11-13 15:04
Articles in Press
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-02-12 18:51
Publish the Manuscript Online	2014-03-12 11:24

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Treatment of gastric cancer
Manuscript Source	Invited Manuscript
All Author List	Michele Orditura, Gennaro Galizia, Vincenzo Sforza, Valentina Gambardella, Alessio Fabozzi, Maria Maddalena Laterza, Francesca Andreozzi, Jole Ventriglia, Beatrice Savastano, Andrea Mabilia, Eva Lieto, Fortunato Ciardiello and Ferdinando De Vita
Funding Agency and Grant Number
Corresponding Author	Michele Orditura, MD, PhD, Division of Medical Oncology, Dipartimento di Medicina, Clinica e Sperimentale ‘F. Magrassi-A. Lanzara’, Seconda Università degli Studi di Napoli, c/o II Policlinico, via S. Pansini 5, 80131 Naples, Italy. michele.orditura@unina2.it
Key Words	Gastric cancer; Surgery; Radiotherapy; Adjuvant chemotherapy; Palliative chemotherapy; Chemoradiation
Core Tip	Surgery remains the only curative therapy of localized gastric cancer, while perioperative and adjuvant chemotherapy, as well as chemoradiation, can improve outcome. Cisplatin and fluoropyrimidine-based chemotherapy, with addition of trastuzumab in human epidermal growth factor receptor 2 positive patients, is the widely used treatment in stage Ⅳ patients. Second-line chemotherapy after progression in patients with good performance status represents a good option.
Publish Date	2014-03-12 11:24
Citation	Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A, Lieto E, Ciardiello F, De Vita F. Treatment of gastric cancer. World J Gastroenterol 2014; 20(7): 1635-1649
URL	http://www.wjgnet.com/1007-9327/full/v20/i7/1635.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i7.1635

Full Article (PDF)	WJG-20-1635.pdf
Full Article (Word)	WJG-20-1635.doc
Manuscript File	5731-Review.doc
Answering Reviewers	5731-Answering reviewers.pdf
Copyright License Agreement	5731-Copyright assignment.pdf
Peer-review Report	5731-Peer reviews.pdf
Scientific Editor Work List	5731-Scientific editor work list.doc